Royalty Pharma Update

• Royalty Pharma, a pharmaceutical royalty company, participated in the Goldman Sachs 46th Annual Global Healthcare Conference.
• As of the latest available data, Royalty Pharma’s stock price closed at $35.4 USD.

Stock Price History

• 52-week high: $35.455 USD
• 52-week low: $24.05 USD

Financial Ratios

• Price-to-earnings ratio: 14.24
• Price-to-book ratio: 2.96

Market Performance

The stock’s recent price movement suggests a relatively stable performance, with the 52-week high and low providing a clear indication of the asset’s price range.